Keyphrases
5-year-old
10%
Alanine Aminotransferase
9%
Bowel Surgery
42%
Clinical Presentation
32%
Clinical Recurrence
8%
Clinical Reports
32%
Corticosteroids
10%
Crohn's Disease
68%
Cytokine Modulation
32%
Disease Activity
16%
Disease Progression
18%
Disease Treatment
32%
Disease-associated
19%
Early Surgery
40%
Early Use
23%
Elevated Liver Enzymes
32%
Immune Globulin
32%
Inception Cohort
10%
Inflammatory Bowel Disease
43%
Inflammatory Bowel Disease Unclassified
8%
Initial Surgery
8%
Interleukin-6
18%
Interleukin-6 Receptor (IL-6R)
10%
Interleukin-8
8%
Intravenous Immunoglobulin (IVIg)
32%
Kawasaki Disease
32%
Liver Disease
32%
Mild Disease
10%
Monitoring Strategy
8%
Normal children
32%
North America
32%
Pediatric Crohn's Disease
32%
Pediatric Inflammatory Bowel Disease
15%
Pediatric Patients
12%
Penetrating Disease
26%
Peripheral Blood
32%
Postoperative Management
8%
Postoperative Recurrence
32%
Prevention Strategies
8%
Rapid Resolution
8%
Refractory Disease
8%
Stricture
12%
Stricturing Disease
13%
Surgery Risk
8%
Symptom Resolution
8%
Therapeutic Management
32%
Ulcerative Colitis
19%
Very Early Onset
21%
Very Early-onset Inflammatory Bowel Disease
32%
Working Diagnosis
20%
Medicine and Dentistry
Abscess Drainage
6%
Alanine Aminotransferase
8%
Autoimmune Hepatitis
5%
Biological Product
13%
Colon
5%
Colon Disease
5%
Crohn's Disease
100%
Disease
10%
Disease Activity
16%
Disease Exacerbation
18%
Diseases
46%
Fistulotomy
6%
Immunomodulating Agent
10%
Inflammatory Bowel Disease
64%
Liver Disease
32%
Liver Enzyme
32%
Mercaptopurine
5%
Mesalazine
5%
Methotrexate
5%
Overlap Syndrome
5%
Patient with Crohn's Disease
13%
Pediatrics
42%
Pediatrics Patient
11%
Primary Sclerosing Cholangitis
5%
Recurrent Disease
32%
Sex Diagnosis
6%
Strictureplasty
6%
Therapeutic Management
32%
Ulcerative Colitis
16%
Immunology and Microbiology
Colon
5%
Crohn's Disease
32%
Cytokine
32%
Immunomodulating Drugs
10%
Inflammatory Bowel Disease
32%
Interleukin 6
27%
Intravenous Immunoglobulin
32%
Kawasaki Disease
32%
Methotrexate
5%
Tumor Necrosis Factor
7%
Ulcerative Colitis
16%
